NRC — NRC HEALTH
—
Nasdaq ·
Health Care ·
Life Sciences Tools & Services ·
CIK 70487 ·
Last close
$21.65
Market Cap
$487.92M
52W High
$23.00
52W Low
$14.60
ADV30
149,135
Next earnings
2026-07-28
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | — | — | — | — | — | — | — |
| Dec 2025 | 35,194,000 | 21,259,000 | 4,669,000 | 1,798,000 | 134,878,000 | 4,139,000 | 120,888,000 |
| Sep 2025 | 34,608,000 | 22,204,000 | 7,738,000 | 4,122,000 | 135,719,000 | 2,219,000 | 121,405,000 |
| Jun 2025 | 34,038,000 | 21,064,000 | 1,588,000 | -106,000 | 141,387,000 | 5,274,000 | 120,059,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$26,450,000
Investing CF
$-10,706,000
Financing CF
$-15,838,000
CapEx
$-10,706,000
Dividends Paid
$-10,978,000
Buybacks
$-20,180,000
EPS Diluted TTM
$0.39
As of
2026-05-10
Balance + Analyst (yfinance extras)
Retained Earnings
$-17,298,000
Inventory
—
Receivables
$11,636,000
ST Investments
—
EBIT TTM
$22,606,000
Pretax Income TTM
$17,846,000
Interest Exp TTM
$4,760,000
Analysts
—
Yahoo Snapshot (yfinance, live)
Total Revenue
$138,642,000
EBITDA
$34,602,000
Free Cash Flow
$19,732,250
Enterprise Value
$564,756,672
Total Cash
$2,547,000
Total Debt
$78,032,000
Shares Out
22,536,696
Trailing EPS
$0.39
Book Value
$0.60
ROE
41.9%
ROA
12.2%
Div Yield
2.76%
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 137,390,000 | 22,590,000 | 11,600,000 | 134,878,000 | 120,888,000 | — | 26,450,000 |
| Dec 2024 | 143,060,000 | 35,194,000 | 24,783,000 | 132,539,000 | 101,255,000 | — | 34,625,000 |
| Dec 2023 | 148,580,000 | 40,045,000 | 30,971,000 | 122,437,000 | 73,482,000 | — | 38,113,000 |
| Dec 2022 | 151,568,000 | 46,543,000 | 31,800,000 | 130,461,000 | 58,428,000 | — | 36,265,000 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$1.07
Max Pain — expiry 2026-12-18 (volume-derived — Yahoo OI feed degraded)
max pain strike: $12.50 · spot: $21.65 · call volume: 653 · put volume: 0Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| MYGN | MYRIAD GENETICS INC | $550.63M | $5.83 | — |
| NNNN | Anbio Biotechnology | $412.14M | $9.39 | — |
| ACHV | ACHIEVE LIFE SCIENCES, INC. | $627.25M | $6.11 | — |
| OABI | OmniAb, Inc. | $331.99M | $2.29 | — |
| TKNO | Alpha Teknova, Inc. | $287.37M | $5.36 | — |
News headlines (Yahoo Finance, 1h cache)
NRC Health and Healthcare Experience Foundation Launch Strategic Partnership to Deepen Support for Improving Experience, Safety, and Workforce Engagement
2026-06-09 13:00 · Yahoo
There May Be Reason For Hope In NRC Health's (NASDAQ:NRC) Disappointing Earnings
2026-05-13 10:20 · Yahoo
NRC Health's Q1 Earnings Fall Y/Y Due to Elevated Operating Costs
2026-05-01 14:00 · Yahoo
NRC Health (NRC) Q1 2026 Earnings Call Highlights: Record TRCV and Landmark Deals Propel Growth
2026-04-29 07:10 · Yahoo
National Research Q1 Earnings Call Highlights
2026-04-28 23:39 · Yahoo
NRC Health Surges 62% in a Year: Should You Buy the Stock?
2026-04-15 17:15 · Yahoo
TSX Penny Stocks With Market Caps Over CA$100M To Consider
2026-04-07 13:05 · Yahoo
What Makes National Research Corporation (NRC) a Good Investment Choice?
2026-03-13 12:05 · Yahoo
NRC's Q4 Earnings Down Y/Y on High Client Attrition, Stock Falls 27%
2026-02-09 17:50 · Yahoo
A Look At The Fair Value Of National Research Corporation (NASDAQ:NRC)
2026-02-04 10:17 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.